Phenotyping by persistent inflammation in systemic sclerosisassociated interstitial lung disease: a EUSTAR database analysis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phenotyping by persistent inflammation in systemic sclerosisassociated interstitial lung disease: a EUSTAR database analysis
Authors
Keywords
-
Journal
THORAX
Volume -, Issue -, Pages thorax-2023-220541
Publisher
BMJ
Online
2023-10-06
DOI
10.1136/thorax-2023-220541
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial
- (2022) Toby M Maher et al. Lancet Respiratory Medicine
- Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial
- (2021) Satoshi Ebata et al. Lancet Rheumatology
- NT-proBNP, hs-cTnT, and CRP predict the risk of cardiopulmonary outcomes in systemic sclerosis: Findings from the Canadian Scleroderma Research Group
- (2021) Mayank Jha et al. Journal of Scleroderma and Related Disorders
- Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database
- (2020) Anna-Maria Hoffmann-Vold et al. ANNALS OF THE RHEUMATIC DISEASES
- Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
- (2020) Dinesh Khanna et al. Lancet Respiratory Medicine
- Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
- (2019) Kevin R. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- High acute phase protein levels correlate with pulmonary and skin involvement in patients with diffuse systemic sclerosis
- (2018) Anna Lis-Święty et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts
- (2018) Elizabeth R Volkmann et al. ANNALS OF THE RHEUMATIC DISEASES
- Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis
- (2017) Nicole S. Goh et al. Arthritis & Rheumatology
- Update of EULAR recommendations for the treatment of systemic sclerosis
- (2016) Otylia Kowal-Bielecka et al. ANNALS OF THE RHEUMATIC DISEASES
- Association between inflammatory biomarkers and all-cause, cardiovascular and cancer-related mortality
- (2016) Archana Singh-Manoux et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial
- (2016) Donald P Tashkin et al. Lancet Respiratory Medicine
- Fitting Linear Mixed-Effects Models Usinglme4
- (2015) Douglas Bates et al. Journal of Statistical Software
- Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis
- (2014) Jacob M. van Laar et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
- (2014) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
- (2013) Frank van den Hoogen et al. ARTHRITIS AND RHEUMATISM
- Does C-Reactive Protein Predict the Long-Term Progression of Interstitial Lung Disease and Survival in Patients With Early Systemic Sclerosis?
- (2013) Xiaochun Liu et al. ARTHRITIS CARE & RESEARCH
- Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database
- (2012) Florian M P Meier et al. ANNALS OF THE RHEUMATIC DISEASES
- Prednisone, Azathioprine, andN-Acetylcysteine for Pulmonary Fibrosis
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Association of C-reactive protein with high disease activity in systemic sclerosis: Results from the Canadian Scleroderma Research Group
- (2012) Chayawee Muangchan et al. ARTHRITIS CARE & RESEARCH
- Predicting treatment outcomes and responder subsets in scleroderma-related interstitial lung disease
- (2011) Michael D. Roth et al. ARTHRITIS AND RHEUMATISM
- Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies
- (2011) M. Elhai et al. RHEUMATOLOGY
- Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database
- (2010) A. J. Tyndall et al. ANNALS OF THE RHEUMATIC DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now